Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatrics · Macrodactyly

Understanding Macrodactyly: Biology and Diagnosis

At a Glance

Macrodactyly is a rare condition causing abnormally large fingers or toes, driven by a localized mosaic mutation in the PIK3CA gene. Diagnosis relies on an MRI showing characteristic nerve enlargement and specialized genetic testing of the affected tissue, rather than standard blood tests.

Macrodactyly is a rare condition where a child is born with one or more abnormally large fingers or toes. While it can be overwhelming for parents, understanding the underlying biology and the specific steps required for diagnosis is the first step in managing your child’s care. Recent advances have shown that macrodactyly is not just a random occurrence; it is a genetic condition caused by specific changes in how cells grow and divide [1][1].

The Biology of Overgrowth

Macrodactyly is now recognized as part of the PIK3CA-Related Overgrowth Spectrum (PROS), a group of disorders caused by mutations in the PIK3CA gene [1][2]. This gene provides instructions for making a protein that helps control cell growth, division, and survival.

  • Mosaicism: Unlike many genetic conditions, the mutation in macrodactyly is mosaic (or somatic). This means the mutation is not present in every cell of the body; it only exists in the cells of the affected finger or toe [3][4].
  • Pathway Overactivation: The mutation causes the PI3K/AKT/mTOR pathway—essentially a “growth switch” inside cells—to be stuck in the “on” position [1][5]. This leads to excessive production of fat, bone, and skin, as well as the enlargement of nerves [1][6].

Identifying Fibrolipomatous Hamartoma (FLH)

A hallmark of macrodactyly is the involvement of the nerves, most commonly the median nerve in the hand [7][6]. The enlarged nerve often develops a condition called Fibrolipomatous Hamartoma (FLH), where the nerve is infiltrated by fat and fibrous tissue [6][8].

The Role of MRI

Magnetic Resonance Imaging (MRI) is the most critical tool for diagnosing macrodactyly and FLH. It allows doctors to see the internal structure of the digit without surgery.

  • Cable-like Appearance: On an MRI, a nerve affected by FLH has a pathognomonic (unmistakable) “coaxial cable” or “spaghetti-like” appearance [7][9]. This is caused by dark nerve fibers being surrounded by bright, overgrown fat.
  • Avoiding Biopsies: Because this MRI finding is so specific, a surgical biopsy of the nerve is usually unnecessary and should often be avoided to prevent damaging the nerve further [7].

Precision Diagnosis and Genetic Testing

Because the mutation is mosaic, traditional blood tests are often unhelpful [10][11].

  • Tissue is Key: To find the mutation, genetic testing must be performed on a sample of the affected tissue—such as skin, fat, or bone taken during a necessary debulking surgery [10][12].
  • Advanced Testing: Labs use a technique called Next-Generation Sequencing (NGS), which can detect the mutation even if it is only present in a small percentage of the cells in the sample [10][4].

Differentiating Macrodactyly from Proteus Syndrome

It is common for parents to encounter information about Proteus syndrome when researching overgrowth. While both involve mosaicism, they are distinct conditions:

Feature Macrodactyly (PROS) Proteus Syndrome
Genetic Cause PIK3CA mutation [1] AKT1 mutation [13]
Growth Pattern Usually limited to digits/limbs [6] Can cause severe, distorting overgrowth across the body [13]
Skin Signs Less common Often involves specific skin growths (cerebriform connective tissue nevi) [13]

Identifying the correct syndrome is vital because it helps doctors predict how the overgrowth might progress and determines if newer, targeted medications might be an option for your child [14][11].

Common questions in this guide

What causes macrodactyly in children?
Macrodactyly is caused by a localized, or mosaic, mutation in the PIK3CA gene. This mutation causes a cellular pathway to stay turned "on," leading to the excessive growth of fat, bone, skin, and nerves in the affected finger or toe.
How is macrodactyly diagnosed?
Doctors primarily use an MRI to look for a specific pattern called fibrolipomatous hamartoma (FLH) in the enlarged nerves. The affected nerve typically shows a distinct "cable-like" or "spaghetti-like" appearance, which can confirm the diagnosis without a surgical biopsy.
Can a blood test detect the gene mutation that causes macrodactyly?
No, standard blood tests are often unhelpful because the mutation is only present in the overgrown tissue. To detect the mutation, doctors must perform advanced genetic testing on a tissue sample taken during a procedure like debulking surgery.
Is macrodactyly the same as Proteus syndrome?
While both conditions involve overgrowth, they have different genetic causes. Macrodactyly is caused by a PIK3CA mutation and is usually limited to the limbs. Proteus syndrome is caused by an AKT1 mutation, can cause severe overgrowth across the body, and often involves specific skin growths.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has my child's overgrowth been confirmed as part of the PIK3CA-Related Overgrowth Spectrum (PROS)?
  2. 2.Does the MRI show fibrolipomatous hamartoma (FLH) or a 'cable-like' appearance in the nerves?
  3. 3.If we proceed with genetic testing, is tissue banking available during their next debulking surgery so we don't need an extra procedure?
  4. 4.How do we distinguish my child's symptoms from other conditions like Proteus syndrome?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    An Analysis of the Pathogenic Genes and Mutation Sites of Macrodactyly.

    Li JF, Tian GL, Pan H, et al.

    Pharmacogenomics and personalized medicine 2022; (15()):55-64 doi:10.2147/PGPM.S346373.

    PMID: 35125881
  2. 2

    Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation.

    Da Costa R, De Almeida S, Chevarin M, et al.

    Biochemical and biophysical research communications 2020; (530(3)):520-526 doi:10.1016/j.bbrc.2020.04.146.

    PMID: 32620236
  3. 3

    Molecular diagnosis of somatic overgrowth conditions: A single-center experience.

    Lalonde E, Ebrahimzadeh J, Rafferty K, et al.

    Molecular genetics & genomic medicine 2019; (7(3)):e536 doi:10.1002/mgg3.536.

    PMID: 30761771
  4. 4

    Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS).

    Gökpınar İli E, Taşdelen E, Durmaz CD, et al.

    American journal of medical genetics. Part A 2022; (188(6)):1792-1800 doi:10.1002/ajmg.a.62709.

    PMID: 35238469
  5. 5

    Activating PIK3CA mutation promotes overgrowth of adipose tissue via inhibiting lipophagy in macrodactyly.

    Yin Y, Zhang X, Lin S, et al.

    Cell death & disease 2025; (16(1)):686 doi:10.1038/s41419-025-08024-x.

    PMID: 41052995
  6. 6

    Macrodystrophia lipomatosa of finger-A rare case report.

    Pratap R, Raj G

    Radiology case reports 2023; (18(4)):1613-1616 doi:10.1016/j.radcr.2023.01.083.

    PMID: 36865622
  7. 7

    Fibrolipomatous hamartoma with macrodactyly and carpal tunnel syndrome.

    Saida T, Sasaki K, Yoshida M, et al.

    Radiology case reports 2023; (18(1)):335-338 doi:10.1016/j.radcr.2022.10.085.

    PMID: 36411853
  8. 8

    Clinical characteristics of 93 cases of isolated macrodactyly of the foot in children.

    Chen W, Tian X, Chen L, Huang W

    Journal of orthopaedic surgery and research 2021; (16(1)):121 doi:10.1186/s13018-020-02196-2.

    PMID: 33557883
  9. 9

    Fibrolipomatous hamartroma with macrodactyly in a 4 years old female patient: A case report.

    Soedjana H, Riestiano BE, Hasibuan LY, Kusumadiningrat VM

    International journal of surgery case reports 2024; (118()):109680 doi:10.1016/j.ijscr.2024.109680.

    PMID: 38669809
  10. 10

    Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.

    Kuentz P, St-Onge J, Duffourd Y, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(9)):989-997 doi:10.1038/gim.2016.220.

    PMID: 28151489
  11. 11

    PIK3CA-related overgrowth with an uncommon phenotype: case report.

    Rotunno R, Diociaiuti A, Pisaneschi E, et al.

    Italian journal of pediatrics 2022; (48(1)):71 doi:10.1186/s13052-022-01268-9.

    PMID: 35551640
  12. 12

    Expanding the phenotypic spectrum of PROS: reclassifying isolated lateralised overgrowth.

    Gazzin A, Reynolds G, Massuras S, et al.

    Journal of medical genetics 2025; (62(4)):276-280 doi:10.1136/jmg-2024-110364.

    PMID: 39870398
  13. 13

    Characterization and Childhood Tumor Risk Assessment of Genetic and Epigenetic Syndromes Associated With Lateralized Overgrowth.

    Griff JR, Duffy KA, Kalish JM

    Frontiers in pediatrics 2020; (8()):613260 doi:10.3389/fped.2020.613260.

    PMID: 33392121
  14. 14

    Four-month-old with severe PIK3CA-related overgrowth spectrum disorder successfully treated with alpelisb.

    Cossio ML, Rodríguez J, Flores JC, et al.

    Pediatric dermatology 2024; (41(4)):714-717 doi:10.1111/pde.15582.

    PMID: 38444084

This page provides educational information about the biology and diagnosis of macrodactyly. It is not a substitute for professional medical advice, diagnosis, or genetic counseling for your child.

Get notified when new evidence is published on Macrodactyly of fingers.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.